Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 16 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8759389

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  2. US 8759353

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  3. US 8759335

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  4. US 8754224

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted
  5. US 8754222

    Process for preparing modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted
  6. US 8748612

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  7. US 8741939

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  8. US 8741912

    Deazapurines useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  9. US 8742122

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  10. US 8741925

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  11. US 8741922

    Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  12. US 8741933

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  13. US 8735593

    Aminopyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 27, 2014 · Expires May 22, 2034

    granted
  14. US 8722889

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 13, 2014 · Expires May 8, 2034

    granted
  15. US 8722704

    Modulators of ATP-binding cassette-transporters

    Vertex Pharmaceuticals Incorporated · Granted May 13, 2014 · Expires May 8, 2034

    granted
  16. US 8716338

    Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted May 6, 2014 · Expires May 1, 2034

    granted
  17. US 8710075

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted
  18. US 8697698

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  19. US 8691848

    Inhibitors of caspases

    Vertex Pharmaceuticals Incorporated · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  20. US 8691758

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  21. US 8686157

    Processes for the facile synthesis of diaryl amines and analogues thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted
  22. US 8686143

    Compounds useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted
  23. US 8674108

    Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  24. US 8674118

    Compounds and methods for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted